Quarterly Financial Information (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]                      
Revenues $ 306,001 $ 282,682 $ 289,681 $ 267,074 $ 263,322 $ 239,599 $ 232,827 $ 224,143 $ 1,145,438 $ 959,891 $ 403,289
Cost of revenues 214,247 201,394 208,852 196,703 183,174 168,821 161,558 155,773 821,196 669,326 254,178
Net income 38,100 14,334 22,293 10,357 36,094 13,784 12,479 10,488 85,083 72,845 (27,052)
Net income attributable to non-controlling interests (21,238) (16,672) (20,173) (17,547) (19,355) (16,906) (17,905) (17,250) (75,630) (71,416) (38,845)
Net income (loss) attributable to Surgery Partners, Inc. $ 16,862 $ (2,338) $ 2,120 $ (7,190) $ 16,739 $ (3,122) $ (5,426) $ (6,762) $ 9,453 $ 1,429 $ (65,897)
Basic net (loss) income per share (in USD per share) $ 0.35 $ (0.05) $ 0.04 $ (0.15) $ 0.35 $ (0.10) $ (0.17) $ (0.21) $ 0.20 $ 0.04 $ (2.04)
Diluted net (loss) income per share (in USD per share) $ 0.35 $ (0.05) $ 0.04 $ (0.15) $ 0.35 $ (0.10) $ (0.17) $ (0.21) $ 0.20 [1] $ 0.04 [1] $ (2.04) [1]
[1] The impact of potentially dilutive securities for the year ended December 31, 2014 was not considered because the effect would be anti-dilutive for the period.